From February 6, 2024 to March 31, 2024, the company has repurchased 1,796,900 shares, representing 0.29% for CNY 22.86 million. With this, the company has completed the repurchase of 1,796,900 shares, representing 0.29% for CNY 22.86 million under the buyback announced on February 6, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.23 CNY | -0.30% | -1.49% | -12.21% |
Apr. 25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
Apr. 24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.21% | 1.11B | |
-5.27% | 12.23B | |
-3.86% | 8.17B | |
+33.66% | 5.74B | |
-7.35% | 4.24B | |
-55.63% | 2.97B | |
+13.62% | 2.73B | |
-3.65% | 2.38B | |
+30.67% | 2.26B | |
-4.31% | 1.87B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.